Antonin K H, Bieck P, Scheurlen M, Jedrychowski M, Malchow H
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):137S-142S. doi: 10.1111/j.1365-2125.1985.tb02754.x.
The systemic availability of oxprenolol after colonic and oral administration has been compared in a crossover study involving six healthy male volunteers. Drug administration into two regions of the colon (caecum and left flexure) was achieved by means of a colonoscopic technique. There were no obvious differences in plasma concentrations after drug administration to the caecum and left flexure, although in one subject it was necessary to repeat colonic administration because of unexpectedly high plasma drug levels on the first occasion. The possible reasons for this abnormal response are discussed. The mean systemic availability of oxprenolol was 82% after colonic compared with oral dosing, although marked differences were observed in individual plasma levels following drug administration by the two routes. The results of this study support the concept of extending the duration of oxprenolol release from a rate-controlled dosage form to permit once-daily administration with this short elimination half-life drug.
在一项涉及六名健康男性志愿者的交叉研究中,对氧烯洛尔经结肠给药和口服给药后的全身可用性进行了比较。通过结肠镜技术将药物输送到结肠的两个区域(盲肠和左结肠弯曲处)。向盲肠和左结肠弯曲处给药后,血浆浓度没有明显差异,不过有一名受试者由于首次给药时血浆药物水平意外升高,需要重复进行结肠给药。讨论了这种异常反应的可能原因。与口服给药相比,氧烯洛尔经结肠给药后的平均全身可用性为82%,尽管通过两种途径给药后个体血浆水平存在显著差异。这项研究的结果支持了从控释剂型延长氧烯洛尔释放时间的概念,以便对这种消除半衰期短的药物进行每日一次给药。